ENVALITH (Envalis) is initiating research coverage of GA technologies. Its first report on GA technologies, which includes RENOSY and ITANDI, is scheduled for publication on 10 September 2026.
ENVALITH (Envalis), a provider of next-generation equity research, announced that it will initiate research coverage of GA technologies. As the first report under the coverage, it plans to publish an earnings preview report on 10 September 2026.
ENVALITH provides reports in 3 languages—Japanese, English and Chinese—and distributes rapid reports immediately after earnings announcements, along with multifaceted analysis, to a global audience. It is distinguished by its delivery of value-added information to investors in Japan and overseas through global terminals and media platforms.
GA technologies includes RENOSY and ITANDI, and the initiation of coverage is intended to provide independent, objective analysis of the company’s corporate value. ENVALITH plans to continue disseminating information through regular report publications.